Literature DB >> 32303922

Facile Approach to Prepare rGO@Fe3O4 Microspheres for the Magnetically Targeted and NIR-responsive Chemo-photothermal Combination Therapy.

Chunyong Liang1, Jiying Song1, Yongguang Zhang1, Yaping Guo1, Meigui Deng2, Wei Gao3, Jimin Zhang4.   

Abstract

Near-infrared (NIR)-light responsive graphene have been shown exciting effect on cancer photothermal ablation therapy. Herein, we report on the preparation of Fe3O4-decorated hollow graphene microspheres (rGO@Fe3O4) by a facile spray drying and coprecipitation method for the magnetically targeted and NIR-responsive chemo-photothermal combination therapy. The microspheres displayed very high specific surface area (~ 120.7 m2 g-1) and large pore volume (~ 1.012 cm3 g-1), demonstrating distinct advantages for a high loading capacity of DOX (~ 18.43%). NIR triggered photothermal effect of the rGO@Fe3O4 microspheres responded in an on-off manner and induced a high photothermal conversion efficiency. Moreover, The Fe3O4 on the microspheres exhibited an excellent tumor cells targeting ability. The chemo-photothermal treatment based on rGO@Fe3O4/DOX showed superior cytotoxicity towards Hela cells in vitro. Our studies indicated that rGO@Fe3O4/DOX microcapsules have great potential in combined chemo-photothermal cancer treatment.

Entities:  

Keywords:  Chemo-photothermal therapy; Magnetic target; NIR response; rGO@Fe3O4 microspheres

Year:  2020        PMID: 32303922     DOI: 10.1186/s11671-020-03320-1

Source DB:  PubMed          Journal:  Nanoscale Res Lett        ISSN: 1556-276X            Impact factor:   4.703


  2 in total

1.  2D layered nanomaterials for therapeutics delivery.

Authors:  Ryan Davis; Richard A Urbanowski; Akhilesh K Gaharwar
Journal:  Curr Opin Biomed Eng       Date:  2021-07-02

Review 2.  PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.

Authors:  Yue Su; Bolun Zhang; Ruowei Sun; Wenfang Liu; Qubo Zhu; Xun Zhang; Rongrong Wang; Chuanpin Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.